The world‐wide incidence of Kaposi's sarcoma in theHIV/AIDSera
- 25 January 2018
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 19 (5) , 355-364
Abstract
Objectives: Kaposi's sarcoma (KS) is a multicentric angioproliferative cancer of endothelial origin typically occurring in the context of immunosuppression or immunodeficiency. Consequently,KSis one of the most common cancers inHIV‐infected individuals and frequently occurs among transplant recipients. Nevertheless, its incidence in different populations is not well understood.Methods: We searched online databases for publications onKSincidence. A random‐effect meta‐analysis was performed to combine theKSincidences and incidence rate ratios (IRRs) for associated risk factors.Results: Seventy‐six eligible studies representing 71 time periods were included. ForHIV‐infected people, the overallKSincidence was 481.54 per 100 000 person‐years with a 95% confidential interval (CI) of 342.36–677.32 per 100 000 person‐years.HIV‐infected men who have sex with men (MSM) had the highest incidence ofKS(1397.11 per 100 000 person‐years; 95%CI870.55–2242.18 per 100 000 person‐years). The incidence ofKSwas significantly lower in female than in male individuals (IRR3.09; 95%CI1.70–5.62). People receiving highly active antiretroviral therapy (HAART) had a lower incidence compared with people who had never receivedHAART(IRR6.57; 95%CI1.91–24.69). The incidence ofKSwas 68.59 (95%CI31.39–149.86) per 100 000 person‐years in transplant recipients, 52.94 (95%CI39.90–70.20) per 100 000 person‐years in children withHIVinfection, and 1.53 (95%CI0.33–7.08) per 100 000 person‐years in the general population.Conclusions: Globally, a relatively high incidence ofKSwas found amongHIV‐seropositive people and, in particular, inHIV‐infectedMSM. The introduction ofHAARThas largely prevented the development ofKS, but it has not entirely removed the challenge ofKS. In Africa, in particular,KSimposes a very heavy disease burden, which can mainly be attributed to the high prevalence ofKS‐associated herpesvirus and poor access toHAART.Keywords
Funding Information
- National Natural Science Foundation of China (81772170)
- Ministry of Education of the People's Republic of China (20120071120050)
This publication has 37 references indexed in Scilit:
- Classic Kaposi sarcomaCanadian Medical Association Journal, 2011
- Kaposi's sarcoma and its associated herpesvirusNature Reviews Cancer, 2010
- Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV SeroconversionJNCI: Journal of the National Cancer Institute, 2010
- Kaposi's sarcoma risk among transplant recipients in the United States (1993–2003)International Journal of Cancer, 2006
- Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cellsBlood, 2005
- Relationship of Kaposi Sarcoma (KS)–Associated Herpesvirus Viremia and KS Disease in ZimbabweClinical Infectious Diseases, 2003
- Kaposi’s sarcoma in liver transplant recipients: Morphological and clinical descriptionLiver Transplantation, 2001
- Incidence and Trends in Kaposi's Sarcoma in the Era of Effective Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcomaNature, 1994